Immune checkpoint inhibitor trials for Melanoma

All Immune checkpoint inhibitor trials · All Melanoma trials

Phase breakdown

Recruiting trials studying Immune checkpoint inhibitor for Melanoma

• Biomarkers in Immunotherapy of Melanoma
  NCT05878977 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
  NCT05522660 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
  NCT07405086 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Immune checkpoint inhibitor for Melanoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.